By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Cambridge Organoid Technology Offers New Path to Reversing Spinal Cord Injuries

Cambridge Organoid Technology Offers New Path to Reversing Spinal Cord Injuries

GMJ
Last updated: 05/06/2026 16:52
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Microscopic view of lab-grown brain organoids showing neural connections and regenerating nerve fibers
Cambridge researchers used lab-grown brain organoids to discover that human neurons lose regenerative capacity during development, but thyroid hormone therapy can restore nerve regrowth by 10-fold. The breakthrough offers new hope for treating paralysis and spinal cord injuries. — Photo: Google DeepMind / Pexels
SHARE
1 min read|147 words

Researchers at Cambridge University have achieved a significant advancement in neural regeneration using laboratory-grown brain and spinal cord organoids. The breakthrough demonstrates that nerve damage previously considered irreversible may be treatable through targeted hormone therapy. Using three-dimensional tissue models grown from human stem cells, the Cambridge team successfully created functional neural circuits capable of transmitting electrical signals and triggering muscle contractions. The research reveals that human neurons progressively lose their regenerative capacity during development, transitioning from near-complete regeneration in embryonic stages to minimal regrowth in adult neurons. However, the study shows this decline is not permanent. When treated with thyroid hormone therapy, adult neurons in the organoid models demonstrated a remarkable 10-fold increase in nerve fiber regrowth. Dr. Stefano Patani and his team believe these findings could unlock new therapeutic strategies for treating paralysis, spinal cord injuries, and neurodegenerative diseases. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Lab-grown brain organoids reveal how to reverse ‘irreversible’ nerve damage →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
England’s Euro 2024 Match Days Saw 17,000 Fewer A&E Visits — Why That Matters for Health Planning

Analysis of NHS accident and emergency data from Euro 2024 reveals just…

Americas Health Leadership: PAHO Executive Committee Endorses Plan to Strengthen Regional Health Systems

The Pan American Health Organization Executive Committee endorsed a comprehensive strategic framework…

UK Orphan Drug Registry Expands Access to Rare Disease Treatments

The UK Medicines and Healthcare products Regulatory Agency (MHRA) maintains a comprehensive…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

FDA Class I recall notice for VOCSN V+Pro ventilators showing medical device safety alert

Class I Recall Alert: Understanding the Highest Level of FDA Medical Device Risk Classification

By
Prof. Giorgi Pkhakadze
07/06/2026
NHS healthcare workers in hospital corridor discussing new uniform policy restrictions

NHS Proposes Political Badge Restrictions for Doctors Following Antisemitism Review

By
Prof. Giorgi Pkhakadze
23/06/2026

SITUATION BRIEF: Ebola Outbreak – Cross-Border Spread from DRC to Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Children walking to damaged school building after climate disaster, symbolizing educational disruption

What You Need to Know: Climate Change and the Education Crisis in Vulnerable Communities

By
Prof. Giorgi Pkhakadze
12/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up